共 50 条
- [21] NEOADJUVANT HIGH-DOSE METHOTREXATE, CISPLATIN, AND DOXORUBICIN FOR THE MANAGEMENT OF PATIENTS WITH NONMETASTIC OSTEOSARCOMA CANCER TREATMENT REPORTS, 1986, 70 (12): : 1431 - 1432
- [23] CLINICAL-PHARMACOLOGY OF METHOTREXATE - PHARMACOKINETICS OF HIGH-DOSE ORAL METHOTREXATE MEDICAL AND PEDIATRIC ONCOLOGY, 1988, 16 (06): : 404 - 404
- [25] PHARMACOKINETICS OF HIGH-DOSE METHOTREXATE (NSC-740) CANCER CHEMOTHERAPY REPORTS PART 3 PROGRAM INFORMATION-SUPPLEMENT, 1975, 6 (01): : 19 - 24
- [27] PHARMACOKINETICS OF HIGH-DOSE METHOTREXATE WITH CITROVORUM FACTOR RESCUE CANCER TREATMENT REPORTS, 1977, 61 (09): : 1665 - 1674
- [30] THE UNCLEAR ROLE OF HIGH-DOSE METHOTREXATE IN ADULT OSTEOSARCOMA (OS) CLINICAL RESEARCH, 1986, 34 (04): : A932 - A932